Ozempic 0.25-0.5 MG/dose pen 3ML
Ended Awarded
- Contract number
- SPE2DB25FGXGA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $15,411
Award facts
- Contract value 100% obligated
- $15,411.40 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $15,411.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ozempic (semaglutide) 0.25-0.5 mg/dose pen 3ml formulations. The contract was competitively awarded without a set-aside designation and is scheduled for completion by July 24, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance. This delivery order is issued under the company's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.9 billion contract vehicle running through December 2026 that establishes AmerisourceBergen as a pharmaceutical prime vendor supporting military healthcare programs globally.
AmerisourceBergen Drug Corp functions as a critical pharmaceutical distributor for federal medical procurement, supplying brand-name and generic medications, vaccines, and specialized healthcare commodities across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company's extensive portfolio of DLA contract awards reflects its competitive capability to fulfill federal medical supply requirements. This specific delivery order for Ozempic represents routine pharmaceutical procurement to support military healthcare operations and aligns with AmerisourceBergen's established role as a major vendor within the DLA's medical supply chain infrastructure.
Quick answers
Who was awarded contract SPE2DB25FGXGA?
SPE2DB25FGXGA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FGXGA worth?
The government has obligated $15,411 on SPE2DB25FGXGA.
Is contract SPE2DB25FGXGA an order under another contract?
Yes. SPE2DB25FGXGA is a delivery order under SPE2DB24D2213, an indefinite delivery contract.
Was contract SPE2DB25FGXGA competed?
The extent of competition for SPE2DB25FGXGA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award